What this means
This is a planned study that has not started enrolling people yet. It will compare an apple extract capsule with a fake capsule to see if it lowers inflammation.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 45–70 · Adults aged 45 to 70 with signs of low-grade inflammation
- Where
- 1 site, including California
The science
- Registered title
- Evaluation of AppleX™ Apple Extract on Anti-Inflammatory and Healthy Aging Effects
- Trial ID
- NCT07678346 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Systemic Inflammation (hsCRP), Healthy Aging, Vitality, Healthy Adult Participants
- What is tested
- Apple Extract, Placebo
- Sponsor
- Nutraland USA, Inc.
- Ages
- 45 Years to 70 Years
- Dates
- First posted Jul 1, 2026 · updated Jul 1, 2026
Registry summary
The goal of this clinical trial is to learn if AppleX™ Apple Extract can help lower systemic inflammation in adults aged 45-70 with signs of low-grade inflammation. It will also look at the extract's effects on fatigue, joint comfort, and biological aging metrics.
The main questions it aims to answer are:
- Does taking AppleX™ Apple Extract daily lower high-sensitivity C-reactive protein (hsCRP) levels, a key marker of inflammation in the blood?
- Does AppleX™ Apple Extract improve participant-reported fatigue and joint comfort?
- Does the extract slow down biological or epigenetic aging metrics compared to a placebo?
Researchers will compare AppleX™ Apple Extract to a placebo (a look-alike capsule that contains no active ingredients) to see if the apple extract has a measurable anti-inflammatory and healthy aging effect.
Sites (1)
- Alethios, Inc., San Francisco, California, United States